Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chemotherapy-naive patients who are histologically or cytologically diagnosed NSCLC with stage IIIB (not applicable of radical thoracic radiation) or stage IV
Patients with normal organ function and bone marrow function
You may not be if
Given radical thoracic radiation for NSCLC or radiation for other than original lesion within 3 weeks
Any peripheral neuropathy above grade 2
Any ascites, pleural effusion or pericardiac effusion which requires treatment
Any uncontrolled concomitant illness
Pregnant or breast-feeding
Clareo Health | A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)
